This study provides evidence that MMR screening provides new information about genetic risk for patients diagnosed with HNPCC and that genes not routinely tested for can play a role in cancer development in HNPCC patients through polygenic interactions that may indeed be causative. This evidence concerns the gene MRC1 and cancer.